New research presented today in the U.K. has suggested that men over the age of 40 with BRCA2 mutations are at greatly increased risk of prostate cancer and should undergo regular screening.
Men Over 40 With BRCA2 Mutations Must Get Prostate Cancer Screening, Experts Say
